Have a feature idea you'd love to see implemented?
Let us know!
MLSS Milestone Scientific Inc
Price (delayed)
$0.797
Market cap
$61.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.07
Enterprise value
$56.19M
Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary
Highlights
The net income has grown by 38% year-on-year and by 35% since the previous quarter
Milestone Scientific's EPS has increased by 30% from the previous quarter and by 30% YoY
The company's quick ratio fell by 23% YoY but it rose by 2.6% QoQ
The revenue is down by 15% year-on-year and by 11% since the previous quarter
The gross profit has declined by 7% since the previous quarter and by 3.4% year-on-year
Key stats
What are the main financial stats of MLSS
Market
Valuations
Earnings
Shares outstanding
77.29M
Market cap
$61.6M
Enterprise value
$56.19M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.74
Price to sales (P/S)
7.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.67
Revenue
$8.42M
EBIT
-$4.77M
EBITDA
-$4.63M
Free cash flow
-$2.74M
Per share
Balance sheet
Liquidity
EPS
-$0.07
Free cash flow per share
-$0.03
Book value per share
$0.1
Revenue per share
$0.11
TBVPS
$0.15
Total assets
$12.01M
Total liabilities
$4.05M
Debt
$340,439
Equity
$7.95M
Working capital
$7.67M
Debt to equity
0.04
Current ratio
3
Quick ratio
1.6
Net debt/EBITDA
1.17
Margins
Efficiency
Dividend
EBITDA margin
-54.9%
Gross margin
72.4%
Net margin
-54.9%
Operating margin
-79.9%
Return on assets
-40.8%
Return on equity
-60.3%
Return on invested capital
-109.4%
Return on capital employed
-58.3%
Return on sales
-56.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MLSS stock price
How has the Milestone Scientific stock price performed over time
Intraday
-2.33%
1 week
-4.56%
1 month
-18.67%
1 year
-11.44%
YTD
15.52%
QTD
-12.47%
Financial performance
How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.42M
Gross profit
$6.1M
Operating income
-$6.73M
Net income
-$4.62M
Gross margin
72.4%
Net margin
-54.9%
The net income has grown by 38% year-on-year and by 35% since the previous quarter
The net margin has grown by 27% YoY and by 26% from the previous quarter
The revenue is down by 15% year-on-year and by 11% since the previous quarter
The company's gross margin rose by 14% YoY and by 4.3% QoQ
Growth
What is Milestone Scientific's growth rate over time
Valuation
What is Milestone Scientific stock price valuation
P/E
N/A
P/B
7.74
P/S
7.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.67
Milestone Scientific's EPS has increased by 30% from the previous quarter and by 30% YoY
The P/B is 45% lower than the 5-year quarterly average of 14.2 but 9% higher than the last 4 quarters average of 7.1
The equity has grown by 7% from the previous quarter
The P/S is 35% less than the 5-year quarterly average of 11.7 but 28% more than the last 4 quarters average of 5.9
The revenue is down by 15% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Milestone Scientific business performance
The company's return on invested capital rose by 42% YoY and by 27% QoQ
MLSS's ROA is up by 36% QoQ and by 28% YoY
The return on equity has increased by 35% since the previous quarter and by 21% year-on-year
Milestone Scientific's ROS has increased by 26% from the previous quarter and by 26% YoY
Dividends
What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MLSS.
Financial health
How did Milestone Scientific financials performed over time
The total assets is 196% greater than the total liabilities
The company's quick ratio fell by 23% YoY but it rose by 2.6% QoQ
The total liabilities has increased by 17% year-on-year and by 4.1% since the previous quarter
The debt is 96% less than the equity
Milestone Scientific's debt to equity has decreased by 33% YoY and by 20% from the previous quarter
The debt has contracted by 24% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.